David Med Fink
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David Med Fink has a total of 174 co-authors. Here are the top co-authors by number of shared publications:
- Deborah S. Hasin
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA
12 shared publications - Sandro Galea
School of Public Health, Boston University, Boston, Massachusetts
10 shared publications Gregory H. Cohen
Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA
8 shared publications- Laura Sampson
Program in Public Health Program, Stony Brook University, Stony Brook, NY 11794, USA
8 shared publications Amy M. Millikan
U.S. Army Public Health Command—Behavioral and Social Health Outcomes Program, Gunpowder, Maryland
6 shared publications- Claire Walsh
Department of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, CA, USA; Institute for Addiction Science, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
6 shared publications
Latest Publications
- 8 March 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 138, 104765
Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients
- 8 March 2025
- Published by Elsevier in International Journal of Drug Policy
- Vol. 138, 104765
Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients
- 16 December 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 54 (1)
Four targets: an enhanced framework for guiding causal inference from observational data
Observational studies play an increasingly important role in estimating causal effects of a treatment or an exposure, especially with the growing availability of routinely collected real-world data. To facilitate drawing causal inference from observational data, we introduce a conceptual framework centered around “four targets”—target estimand, target population, target trial, and target validity. We illustrate the utility of our proposed “four targets” framework with the example of buprenorphine dosing for treating opioid use disorder, explaining the rationale and process for employing the framework to guide causal thinking from observational data. The “four targets” framework is beneficial for those new to epidemiologic research, enabling them to grasp fundamental concepts and acquire the skills necessary for drawing reliable causal inferences from observational data.
- 16 December 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 54 (1)
Four targets: an enhanced framework for guiding causal inference from observational data
Observational studies play an increasingly important role in estimating causal effects of a treatment or an exposure, especially with the growing availability of routinely collected real-world data. To facilitate drawing causal inference from observational data, we introduce a conceptual framework centered around “four targets”—target estimand, target population, target trial, and target validity. We illustrate the utility of our proposed “four targets” framework with the example of buprenorphine dosing for treating opioid use disorder, explaining the rationale and process for employing the framework to guide causal thinking from observational data. The “four targets” framework is beneficial for those new to epidemiologic research, enabling them to grasp fundamental concepts and acquire the skills necessary for drawing reliable causal inferences from observational data.
- 13 March 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (6) , 1912-1922
HealthCall: Smartphone Enhancement of Brief Interventions to Improve HIV Medication Adherence Among Patients in HIV Care
Heavy drinking among people living with HIV (PLWH) reduces ART adherence and worsens health outcomes. Lengthy interventions are not feasible in most HIV care settings, and patients infrequently follow referrals to outside treatment. Utilizing visual and video features of smartphone technology, we developed HealthCall as an electronic means of increasing patient involvement in a brief intervention to reduce drinking and improve ART adherence. The objective of the current study is to evaluate the efficacy of HealthCall to improve ART adherence among PLWH who drink heavily when paired with two brief interventions: the National Institute on Alcoholism and Alcohol Abuse (NIAAA) Clinician’s Guide (CG) or Motivational Interviewing (MI). Therefore, we conducted a 1:1:1 randomized trial among 114 participants with alcohol dependence at a large urban HIV clinic. Participants were randomized to one of three groups: (1) CG only (n = 37), (2) CG and HealthCall (n = 38), or (3) MI and HealthCall (n = 39). Baseline interventions targeting drinking reduction and ART adherence were ~ 25 min, with brief (10–15 min) booster sessions at 30 and 60 days. The outcome was ART adherence assessed using unannounced phone pill-count method (possible adherence scores: 0–100%) at 30-day, 60-day, 3, 6, and 12 months. Analyses were conducted using generalized linear mixed models with pre-planned contrasts. Of the 114 enrolled patients, 58% were male, 75% identified as Black/African American, 28% were Hispanic, and 62% had less than a high school education. The mean age was 47.5 years (standard deviation [SD] 10 years) and the mean number of years since they were diagnosed with HIV was 18.6 (SD 7.6). Participants assigned to HealthCall to extend the CG had increased levels of ART adherence at 60-day and 6-month follow-up (compared to CG only), although there was no statistically significant difference by 12-month follow-up. Participants who were assigned to HealthCall to extend the MI never had statistically significant higher levels of ART adherence. These results suggest that the use of a smartphone app can be used to initially extend the reach of a brief drinking intervention to improve ART adherence over a short period of time; however, sustained long-term improvements in ART adherence after intervention activity ends remains a challenge.
- 13 March 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (6) , 1912-1922
HealthCall: Smartphone Enhancement of Brief Interventions to Improve HIV Medication Adherence Among Patients in HIV Care
Heavy drinking among people living with HIV (PLWH) reduces ART adherence and worsens health outcomes. Lengthy interventions are not feasible in most HIV care settings, and patients infrequently follow referrals to outside treatment. Utilizing visual and video features of smartphone technology, we developed HealthCall as an electronic means of increasing patient involvement in a brief intervention to reduce drinking and improve ART adherence. The objective of the current study is to evaluate the efficacy of HealthCall to improve ART adherence among PLWH who drink heavily when paired with two brief interventions: the National Institute on Alcoholism and Alcohol Abuse (NIAAA) Clinician’s Guide (CG) or Motivational Interviewing (MI). Therefore, we conducted a 1:1:1 randomized trial among 114 participants with alcohol dependence at a large urban HIV clinic. Participants were randomized to one of three groups: (1) CG only (n = 37), (2) CG and HealthCall (n = 38), or (3) MI and HealthCall (n = 39). Baseline interventions targeting drinking reduction and ART adherence were ~ 25 min, with brief (10–15 min) booster sessions at 30 and 60 days. The outcome was ART adherence assessed using unannounced phone pill-count method (possible adherence scores: 0–100%) at 30-day, 60-day, 3, 6, and 12 months. Analyses were conducted using generalized linear mixed models with pre-planned contrasts. Of the 114 enrolled patients, 58% were male, 75% identified as Black/African American, 28% were Hispanic, and 62% had less than a high school education. The mean age was 47.5 years (standard deviation [SD] 10 years) and the mean number of years since they were diagnosed with HIV was 18.6 (SD 7.6). Participants assigned to HealthCall to extend the CG had increased levels of ART adherence at 60-day and 6-month follow-up (compared to CG only), although there was no statistically significant difference by 12-month follow-up. Participants who were assigned to HealthCall to extend the MI never had statistically significant higher levels of ART adherence. These results suggest that the use of a smartphone app can be used to initially extend the reach of a brief drinking intervention to improve ART adherence over a short period of time; however, sustained long-term improvements in ART adherence after intervention activity ends remains a challenge.
- 14 February 2024
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 59 (7) , 1087-1112
Social and economic determinants of drug overdose deaths: a systematic review of spatial relationships
Purpose To synthesize the available evidence on the extent to which area-level socioeconomic conditions are associated with drug overdose deaths in the United States. Methods We performed a systematic review (in MEDLINE, EMBASE, PsychINFO, Web of Science, EconLit) for papers published prior to July 2022. Eligible studies quantitatively estimated the association between an area-level measure of socioeconomic conditions and drug overdose deaths in the US, and were published in English. We assessed study quality using the Effective Public Health Practice Project Quality Assessment Tool. The protocol was preregistered at Prospero (CRD42019121317). Results We identified 28 studies that estimated area-level effects of socioeconomic conditions on drug overdose deaths in the US. Studies were scored as having moderate to serious risk of bias attributed to both confounding and in analysis. Socioeconomic conditions and drug overdose death rates were moderately associated, and this was a consistent finding across a large number of measures and differences in study designs (e.g., cross-sectional versus longitudinal), years of data analyzed, and primary unit of analysis (e.g., ZIP code, county, state). Conclusions This review highlights the evidence for area-level socioeconomic conditions are an important factor underlying the geospatial distribution of drug overdose deaths in the US and the need to understand the mechanisms underlying these associations to inform future policy recommendations. The current evidence base suggests that, at least in the United States, employment, income, and poverty interventions may be effective targets for preventing drug overdose mortality rates.
- 14 February 2024
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 59 (7) , 1087-1112
Social and economic determinants of drug overdose deaths: a systematic review of spatial relationships
Purpose To synthesize the available evidence on the extent to which area-level socioeconomic conditions are associated with drug overdose deaths in the United States. Methods We performed a systematic review (in MEDLINE, EMBASE, PsychINFO, Web of Science, EconLit) for papers published prior to July 2022. Eligible studies quantitatively estimated the association between an area-level measure of socioeconomic conditions and drug overdose deaths in the US, and were published in English. We assessed study quality using the Effective Public Health Practice Project Quality Assessment Tool. The protocol was preregistered at Prospero (CRD42019121317). Results We identified 28 studies that estimated area-level effects of socioeconomic conditions on drug overdose deaths in the US. Studies were scored as having moderate to serious risk of bias attributed to both confounding and in analysis. Socioeconomic conditions and drug overdose death rates were moderately associated, and this was a consistent finding across a large number of measures and differences in study designs (e.g., cross-sectional versus longitudinal), years of data analyzed, and primary unit of analysis (e.g., ZIP code, county, state). Conclusions This review highlights the evidence for area-level socioeconomic conditions are an important factor underlying the geospatial distribution of drug overdose deaths in the US and the need to understand the mechanisms underlying these associations to inform future policy recommendations. The current evidence base suggests that, at least in the United States, employment, income, and poverty interventions may be effective targets for preventing drug overdose mortality rates.
Understanding the differential effect of local socio‐economic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties
Background and aims: Both local socio‐economic conditions and prescription opioid supply are associated with drug overdose deaths, which exhibit substantial geographical heterogeneity across the United States. We measured whether the associations of prescription opioid supply with drug overdose deaths vary by local socio‐economic conditions.Design: Ecological county‐level study, including 3109 US counties between 2006 and 2019 (n = 43 526 county‐years) using annual mortality data.Setting: United States.Cases: A total of 711 447 drug overdose deaths.Measurements: We modeled overdose counts using Bayesian hierarchical Poisson models, estimating associations between four types of drug overdose deaths (deaths involving any drugs, any opioid, prescription opioids only and heroin), prescription opioid supply and five socio‐economic indicators: unemployment, poverty rate, income inequality, Rey index (components include mean household income, % high school graduates, % blue‐collar workers and unemployment rate), and American human development index (HDI; an indicator of community wellbeing).Findings: Drug overdose deaths and all substance‐specific overdose deaths were higher in counties with higher income inequality [adjusted odds ratios (aORs) = 1.09–1.13], Rey index (aORs = 1.15–1.21) and prescription opioid supply (aORs = 1.14–1.21), and lower in counties with higher HDI scores (aORs = 0.75–0.92). Poverty rate, income inequality and HDI scores were found to modify the effect of prescription opioid supply on heroin overdose deaths. The plot of the interactions showed that when disadvantage is high, increasing prescription opioid supply does not increase heroin overdose deaths. The less disadvantage there is, indicated by lower poverty rates, higher HDI scores and lower income inequality, the greater the effect of increasing prescription opioid supply relative to population size on heroin overdose deaths in US counties.Conclusions: In the United States, prescription opioid supply is associated with higher drug overdose deaths; associations are stronger in counties with less disadvantage and less income inequality, but only for heroin overdose deaths.
Understanding the differential effect of local socio‐economic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties
Background and aims: Both local socio‐economic conditions and prescription opioid supply are associated with drug overdose deaths, which exhibit substantial geographical heterogeneity across the United States. We measured whether the associations of prescription opioid supply with drug overdose deaths vary by local socio‐economic conditions.Design: Ecological county‐level study, including 3109 US counties between 2006 and 2019 (n = 43 526 county‐years) using annual mortality data.Setting: United States.Cases: A total of 711 447 drug overdose deaths.Measurements: We modeled overdose counts using Bayesian hierarchical Poisson models, estimating associations between four types of drug overdose deaths (deaths involving any drugs, any opioid, prescription opioids only and heroin), prescription opioid supply and five socio‐economic indicators: unemployment, poverty rate, income inequality, Rey index (components include mean household income, % high school graduates, % blue‐collar workers and unemployment rate), and American human development index (HDI; an indicator of community wellbeing).Findings: Drug overdose deaths and all substance‐specific overdose deaths were higher in counties with higher income inequality [adjusted odds ratios (aORs) = 1.09–1.13], Rey index (aORs = 1.15–1.21) and prescription opioid supply (aORs = 1.14–1.21), and lower in counties with higher HDI scores (aORs = 0.75–0.92). Poverty rate, income inequality and HDI scores were found to modify the effect of prescription opioid supply on heroin overdose deaths. The plot of the interactions showed that when disadvantage is high, increasing prescription opioid supply does not increase heroin overdose deaths. The less disadvantage there is, indicated by lower poverty rates, higher HDI scores and lower income inequality, the greater the effect of increasing prescription opioid supply relative to population size on heroin overdose deaths in US counties.Conclusions: In the United States, prescription opioid supply is associated with higher drug overdose deaths; associations are stronger in counties with less disadvantage and less income inequality, but only for heroin overdose deaths.
- 9 January 2023
- Published by Elsevier in Addictive Behaviors
- Vol. 140, 107617
Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021
- 9 January 2023
- Published by Elsevier in Addictive Behaviors
- Vol. 140, 107617
Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021
- 21 September 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 155, 387-394
Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use
- 21 September 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 155, 387-394
Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use
- 17 March 2022
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 234, 109411
Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use
- 17 March 2022
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 234, 109411
Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use
- 8 February 2022
- Published by Elsevier in The Journal of Pain
- Vol. 23 (7) , 1187-1195
Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018
- 8 February 2022
- Published by Elsevier in The Journal of Pain
- Vol. 23 (7) , 1187-1195
Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018